• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉旁路移植术(CABG)后30天死亡率的序贯逻辑模型:术前、术中和术后经验——以色列冠状动脉旁路移植术研究(ISCAB)。三种冠状动脉旁路移植术后早期死亡率模型。

Sequential logistic models for 30 days mortality after CABG: pre-operative, intra-operative and post-operative experience--The Israeli CABG study (ISCAB). Three models for early mortality after CABG.

作者信息

Simchen E, Galai N, Zitser-Gurevich Y, Braun D, Mozes B

机构信息

School of Public Health, Hebrew University and Hadassah, Jerusalem, Israel.

出版信息

Eur J Epidemiol. 2000 Jun;16(6):543-55. doi: 10.1023/a:1007658719671.

DOI:10.1023/a:1007658719671
PMID:11049098
Abstract

OBJECTIVES

The goal of this paper was to examine the added effect of operative and post-operative variables on 30 days mortality, in addition to patients' case-mix factors.

SETTING AND DESIGN

A prospective study of 4835 patients, 95% of all Israeli patients who underwent coronary artery bypass grafting (CABG) in 1994. Information related to risk of death was collected at admission to hospital (preceding the operation), at time of the operation and in the immediate post-operative period. Deaths were independently ascertained.

METHOD

Data collectors followed every patient from admission to discharge. Sequential logistic models were constructed for the 'case-mix', 'operative' and the 'post-operative' periods in chronological order. Each model incorporated and adjusted for the risk estimated at the previous point in time, by forcing individual risk scores.

RESULTS

Significant pre-operative risk factors for 30 days mortality, in the case-mix model included mainly severity of illness characteristics, such as, left ventricular dysfunction and emergency admission, (c-statistic 78.8%). Model 2 (the 'operation' model) included in addition to the case-mix score, excessive duration of the operation per graft, bleeding, etc. (c-statistic 85.3%). The post-operative model showed the added effect of the post-operative factors such as low haemoglobin, additional surgery, and excessive time on respirator, (c-statistic 92.4%).

CONCLUSIONS

The sequential analysis was an efficient method for updating patients' risk over time, where the number of events was small, relative to the number of risk factors. The addition of peri-operative factors increased significantly the predictive power of the model, adding clinical insights to the role of the hospital experience on 30 days mortality.

摘要

目的

本文的目的是研究手术及术后变量对30天死亡率的附加影响,以及患者的病例组合因素。

设置与设计

对4835例患者进行的前瞻性研究,这些患者占1994年以色列所有接受冠状动脉搭桥术(CABG)患者的95%。在入院时(手术前)、手术时和术后即刻收集与死亡风险相关的信息。死亡情况由独立人员确定。

方法

数据收集人员跟踪每位患者从入院到出院的情况。按时间顺序为“病例组合”“手术”和“术后”阶段构建序贯逻辑模型。每个模型通过强制个体风险评分纳入并调整上一个时间点估计的风险。

结果

在病例组合模型中,30天死亡率的显著术前风险因素主要包括疾病严重程度特征,如左心室功能障碍和急诊入院(c统计量为78.8%)。模型2(“手术”模型)除病例组合评分外,还包括每个移植物手术时间过长、出血等因素(c统计量为85.3%)。术后模型显示了术后因素如低血红蛋白、再次手术和呼吸机使用时间过长的附加影响(c统计量为92.4%)。

结论

序贯分析是一种随着时间更新患者风险的有效方法,在事件数量相对于风险因素数量较少的情况下尤为适用。围手术期因素的加入显著提高了模型的预测能力,为医院经验对30天死亡率的作用提供了临床见解。

相似文献

1
Sequential logistic models for 30 days mortality after CABG: pre-operative, intra-operative and post-operative experience--The Israeli CABG study (ISCAB). Three models for early mortality after CABG.冠状动脉旁路移植术(CABG)后30天死亡率的序贯逻辑模型:术前、术中和术后经验——以色列冠状动脉旁路移植术研究(ISCAB)。三种冠状动脉旁路移植术后早期死亡率模型。
Eur J Epidemiol. 2000 Jun;16(6):543-55. doi: 10.1023/a:1007658719671.
2
Prediction of readmissions after CABG using detailed follow-up data: the Israeli CABG Study (ISCAB).利用详细随访数据预测冠状动脉旁路移植术后再入院情况:以色列冠状动脉旁路移植术研究(ISCAB)
Med Care. 1999 Jul;37(7):625-36. doi: 10.1097/00005650-199907000-00002.
3
Effect of perioperative complications on excess mortality among women after coronary artery bypass: the Israeli Coronary Artery Bypass Graft Study (ISCAB).围手术期并发症对冠状动脉搭桥术后女性额外死亡率的影响:以色列冠状动脉搭桥术研究(ISCAB)
J Thorac Cardiovasc Surg. 2002 Mar;123(3):517-24. doi: 10.1067/mtc.2002.120012.
4
Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Israeli Coronary Artery Bypass (ISCAB) Study Consortium.
Am J Cardiol. 1998 Jan 1;81(1):7-11. doi: 10.1016/s0002-9149(97)00797-2.
5
Impact of Pre-, Intra-and Post-Operative Parameters on In-Hospital Mortality in Patients Undergoing Emergency Coronary Artery Bypass Grafting: A Scarce Single-Center Experience in Resource-Scare Setting.在资源匮乏的环境下,探讨术前、术中和术后参数对行急诊冠状动脉旁路移植术患者住院死亡率的影响:一项罕见的单中心经验。
Vasc Health Risk Manag. 2021 May 17;17:211-226. doi: 10.2147/VHRM.S303726. eCollection 2021.
6
Clinical characteristics and in-hospital outcomes of patients with cardiogenic shock undergoing coronary artery bypass surgery: insights from the Society of Thoracic Surgeons National Cardiac Database.接受冠状动脉搭桥手术的心源性休克患者的临床特征及院内结局:来自胸外科医师协会国家心脏数据库的见解
Circulation. 2008 Feb 19;117(7):876-85. doi: 10.1161/CIRCULATIONAHA.107.728147. Epub 2008 Feb 4.
7
Reoperative coronary artery bypass procedures: risk factors for early mortality and late survival.再次冠状动脉搭桥手术:早期死亡率和晚期生存率的危险因素
Eur J Cardiothorac Surg. 1997 Jan;11(1):129-33. doi: 10.1016/s1010-7940(96)01030-5.
8
Predictors of death during 5 years after coronary artery bypass grafting.
Int J Cardiol. 1998 Mar 13;64(1):15-23. doi: 10.1016/s0167-5273(97)00299-4.
9
[Advantages of off-pump coronary bypass surgery over conventional coronary bypass surgery].非体外循环冠状动脉搭桥手术相对于传统冠状动脉搭桥手术的优势
Rev Port Cir Cardiotorac Vasc. 2010 Oct-Dec;17(4):217-28.
10
Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery.围手术期红细胞输注对冠状动脉搭桥手术后30天和1年死亡率的影响。
Eur J Cardiothorac Surg. 2005 Apr;27(4):592-8. doi: 10.1016/j.ejcts.2005.01.030.

引用本文的文献

1
Community distress and risk of adverse outcomes after peripheral vascular intervention.周围血管介入术后的社区痛苦和不良结局风险。
J Vasc Surg. 2023 Jul;78(1):166-174.e3. doi: 10.1016/j.jvs.2023.03.027. Epub 2023 Mar 20.

本文引用的文献

1
A national study of postoperative mortality associated with coronary artery bypass grafting in Israel. ISCAB Consortium. Israel Coronary Artery Bypass Study.
Ann Thorac Surg. 1998 Oct;66(4):1254-62; discussion 1263. doi: 10.1016/s0003-4975(98)00586-4.
2
Israeli women were at a higher risk than men for mortality following coronary bypass surgery.
Eur J Epidemiol. 1997 Jul;13(5):503-9. doi: 10.1023/a:1007349230374.
3
Mortality during the two years after coronary artery bypass grafting in relation to perioperative factors and urgency of operation.
Eur J Cardiothorac Surg. 1995;9(12):685-91. doi: 10.1016/s1010-7940(05)80126-5.
4
Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations.
因出血而再次手术探查是心脏手术后不良预后的一个风险因素。
J Thorac Cardiovasc Surg. 1996 May;111(5):1037-46. doi: 10.1016/s0022-5223(96)70380-x.
5
A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group.一项旨在改善冠状动脉搭桥手术相关医院死亡率的区域性干预措施。新英格兰北部心血管疾病研究组。
JAMA. 1996 Mar 20;275(11):841-6.
6
A model for predicting transfusion after coronary artery bypass grafting.一种冠状动脉搭桥术后输血预测模型。
Ann Thorac Surg. 1996 Jan;61(1):27-32. doi: 10.1016/0003-4975(95)00808-X.
7
Survival 15 to 20 years after coronary bypass surgery for angina.
J Am Coll Cardiol. 1993 Jan;21(1):151-7. doi: 10.1016/0735-1097(93)90730-o.
8
Mortality and myocardial infarction after coronary artery surgery. A review of 12,003 patients.冠状动脉手术后的死亡率和心肌梗死。对12003例患者的回顾。
Med J Aust. 1993 Aug 2;159(3):166-70.
9
Chance, continuity, and change in hospital mortality rates. Coronary artery bypass graft patients in California hospitals, 1983 to 1989.医院死亡率的机遇、连续性与变化。1983年至1989年加利福尼亚州医院的冠状动脉搭桥手术患者
JAMA. 1993 Jul 21;270(3):331-7.
10
Coronary artery bypass grafting: the Society of Thoracic Surgeons National Database experience.冠状动脉搭桥术:胸外科医师协会国家数据库经验
Ann Thorac Surg. 1994 Jan;57(1):12-9. doi: 10.1016/0003-4975(94)90358-1.